Explore
Validate
LearnABIN955062
antibody from antibodies-online
Targeting: TADA3
ADA3, FLJ20221, FLJ21329, hADA3, NGG1, TADA3L
Western blot
ELISAAntibody data
- Antibody Data
- Antigen structure
- References [5]
- Comments [0]
- Validations
- Western blot [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN955062 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-Transcriptional Adaptor 3 (TADA3) (C-Term), (AA 385-414) antibody
- Antibody type
- Polyclonal
- Antigen
- KLH conjugated synthetic peptide between 385-414 amino acids from the C-terminal region of human TADA3L
- Description
- Affinity chromatography on Protein A
- Reactivity
- Human
- Host
- Rabbit
- Epitope
- C-Term,AA 385-414
- Vial size
- 0.4 mL
- Concentration
- 0.25 mg/mL
- Storage
- Store the antibody undiluted at 2-8°C for one month or (in aliquots) at -20°C for longer.
- Handling
- Avoid repeated freezing and thawing.
Submitted references Human ADA3 regulates RARalpha transcriptional activity through direct contact between LxxLL motifs and the receptor coactivator pocket.
Variation at the NFATC2 locus increases the risk of thiazolidinedione-induced edema in the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) study.
Gene-centric association signals for lipids and apolipoproteins identified via the HumanCVD BeadChip.
HPV16 E6-induced and E6AP-dependent inhibition of the transcriptional coactivator hADA3 in human cervical carcinoma cells.
Human ATAC Is a GCN5/PCAF-containing acetylase complex with a novel NC2-like histone fold module that interacts with the TATA-binding protein.
Li CW, Ai N, Dinh GK, Welsh WJ, Chen JD
Nucleic acids research 2010 Sep;38(16):5291-303
Nucleic acids research 2010 Sep;38(16):5291-303
Variation at the NFATC2 locus increases the risk of thiazolidinedione-induced edema in the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) study.
Bailey SD, Xie C, Do R, Montpetit A, Diaz R, Mohan V, Keavney B, Yusuf S, Gerstein HC, Engert JC, Anand S, DREAM investigators
Diabetes care 2010 Oct;33(10):2250-3
Diabetes care 2010 Oct;33(10):2250-3
Gene-centric association signals for lipids and apolipoproteins identified via the HumanCVD BeadChip.
Talmud PJ, Drenos F, Shah S, Shah T, Palmen J, Verzilli C, Gaunt TR, Pallas J, Lovering R, Li K, Casas JP, Sofat R, Kumari M, Rodriguez S, Johnson T, Newhouse SJ, Dominiczak A, Samani NJ, Caulfield M, Sever P, Stanton A, Shields DC, Padmanabhan S, Melander O, Hastie C, Delles C, Ebrahim S, Marmot MG, Smith GD, Lawlor DA, Munroe PB, Day IN, Kivimaki M, Whittaker J, Humphries SE, Hingorani AD, ASCOT investigators, NORDIL investigators, BRIGHT Consortium
American journal of human genetics 2009 Nov;85(5):628-42
American journal of human genetics 2009 Nov;85(5):628-42
HPV16 E6-induced and E6AP-dependent inhibition of the transcriptional coactivator hADA3 in human cervical carcinoma cells.
Hu Y, Ye F, Lu W, Hong D, Wan X, Xie X
Cancer investigation 2009 Mar;27(3):298-306
Cancer investigation 2009 Mar;27(3):298-306
Human ATAC Is a GCN5/PCAF-containing acetylase complex with a novel NC2-like histone fold module that interacts with the TATA-binding protein.
Wang YL, Faiola F, Xu M, Pan S, Martinez E
The Journal of biological chemistry 2008 Dec 5;283(49):33808-15
The Journal of biological chemistry 2008 Dec 5;283(49):33808-15
No comments: Submit comment
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- TADA3L Antibody (C-term) (Cat. #AP54140PU-N) western blot analysis in Hela cell line lysates (35μg/lane).This demonstrates the TADA3L antibody detected the TADA3L protein (arrow).
